This is a Study to Verify if Periarticular Hip Injection of Corticosteroid After Hip Replacement Reduce the Pain and the Hospitalisation Time

Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age50-90
SponsorEnte Ospedaliero Cantonale, Bellinzona

About this trial

The investigators are going to evaluate if periarticular corticosteroid injection during endoprothesis implantation can lead to any advantage to the patients, namely if it can reduce post-operative pain, lenght and cost of hospitalisation, use of analgesics drugs.

Eligibility criteria

Qualifiers

Patients undergoing unilateral cemented hip endoprosthesis for femoral neck fracture

Patients aged 50-90 years old

Patients with a BMI >18.5 and <35

Patients able to provide informed consent and follow all the study procedures as indicated by the protocol

Disqualifiers

Contraindications to steroids

Revision endoprosthesis

Active steroid or immunosuppressive therapy in the last 30 days before the operation

Pregnant or breast-feeding women

Trial design

Treatments tested in this trial

  • Dexamethasone is a steroid drug and will be administered as an injectable solution (4mg/ml)

Treatment groups

110 Participants
are divided into 2 treatment groups